BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 16968988)

  • 1. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
    Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
    Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.
    Corell P; Gustafsson F; Kistorp C; Madsen LH; Schou M; Hildebrandt P
    Int J Cardiol; 2007 May; 117(3):395-402. PubMed ID: 16919342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation.
    Cao H; Xue L; Wu Y; Ma H; Chen L; Wang X; Zhu Q; Dai N; Chen Y
    Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular reverse remodeling early after mitral valve repair for severe chronic mitral regurgitation with atrial fibrillation.
    Song BG; On YK; Jeon ES; Park JH; Choi JO; Lee SC; Park SW; Kim JS; Park PW
    Cardiology; 2009; 114(2):132-41. PubMed ID: 19521078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion.
    Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Arnesen H; Smith P
    Int J Cardiol; 2009 Jan; 131(2):234-9. PubMed ID: 18201783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men.
    Laukkanen JA; Kurl S; Ala-Kopsala M; Vuolteenaho O; Ruskoaho H; Nyyssönen K; Salonen JT
    Eur Heart J; 2006 May; 27(10):1230-7. PubMed ID: 16621869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma renin activity in heart failure.
    Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
    Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
    Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
    J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.